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Retinoic acid (RA), which is the biologically active form of vitamin A, acts through the
nuclear hormone receptor RAR (RA receptor) to induce either gene activation or repres-
sion. RA production and its effects have been linked tomacrophages, dendritic cells, T and
B cells, and iNKT cells in the immune system and play pro- as well as anti-inflammatory
roles depending on the cell type and the immune context. In this issue of the European
Journal of Immunology, Lee et al. [Eur. J. Immunol. 2012. 42: 1685–1694] show that RA ame-
liorates Con A-induced murine hepatitis by selectively downmodulating IFN-γ and IL-4
production in disease-causing NKT cells in the liver. Remarkably, this effect is restricted
to this liver disease model and does not apply to αGalCer-induced murine liver injury,
which is driven by other cytokines. The study identifies retinoid signaling as an important
endogenous mechanism controlling immune reactions and also as a potential pharma-
cological target for treatment of hepatic liver injury. Furthermore, the study by Lee et al.
provides additional support for the concept of metabolic regulation of immune function.
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Presently there is an increased understanding and appreciation
of the role that metabolic and lipid signaling plays in immune
regulatory processes in multiple cell types (reviewed in [1]). For
example, the orange pigment of carrots, beta-carotene, contributes
to vitamin A levels in the body. Vitamin A is further processed
into retinol, which is taken up by cells and oxidized into reti-
naldehyde by retinol dehydrogenase (alcohol dehydrogenase);
retinaldehyde is subsequently oxidized by retinaldehyde dehydro-
genase (RALDH) into retinoic acid (RA) (reviewed in [2]). RA
(all-trans retinoic acid, RA) is one of the key biologically active
compounds of vitamin A, the other (11-cis retinal) is involved in
vision.
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RA acts as a ligand for one of the members of the nuclear hor-
mone receptor superfamily, namely the RAR:RXR (RA receptor:
retinoid X receptor) heterodimer [1]. In the absence of ligand,
this receptor heterodimer binds to specific regulatory regions,
termed response elements, of genes in the genome and represses
their transcription. Upon ligand binding, the receptor heterodimer
becomes activated and typically increases transcription [1,3]. In
addition, the ligand-bound receptor can also bind to other tran-
scription factors (e.g. NF-κB, AP1) via protein–protein interactions
without directly binding to DNA, and by doing so can interferewith
(i.e. repress) the transcriptional activity of these factors. This phe-
nomenon is termed transrepression and is particularly important
in the control of inflammation [1]. Therefore, the production and
degradation of RA has to be very tightly regulated in order to coor-
dinate its activating/inhibitory activities in the various cell types
and tissues on which it acts. One of the functions of the RAR:RXR
heterodimer is to turn on the degradation of RA by activating the
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expression of a p450 enzyme CYP26 [3], thus forming a feedback
loop to control RA actions.
The cellular activities of RA are widespread. It regulates
cell proliferation and differentiation in many cancer cell lines,
keratinocytes aswell as cells of the immune system such asmyeloid
cells (reviewed in [1,4]). These activities were typically identified
by using exogenous, often synthetic activators or antagonists of
RAR [1]. However, there is validation of these somewhat “artificial
systems” since it is also well established that endogenous retinoids
have immunomodulatory effects. For example, vitamin A defi-
ciency increases childhood mortality and morbidity and increases
an individual’s susceptibility to infectious diseases (reviewed in
[5]). In addition, there have been a large number of studies on
the role of RA and/or RAR in hematopoietic differentiation and
function. Of note, RAR is known to be expressed in nearly all
hematopoietic lineages and to have roles in early myeloid differ-
entiation and granulopoiesis [6,7]. RA has a dual effect on differ-
entiation by either inducing maturation or cell death, depending
on the cellular context. It also blocks erythroid differentiation by
downregulating GATA-1 [8].
Importantly, there is evidence for both pro- and anti-
inflammatory activities of RA in macrophages. Regarding its anti-
inflammatory actions, it has been documented that RA inhibits
nitric oxide and TNF production in peritoneal macrophages [9],
and that it enhances IL-10 production and reduces TNF-α and
IL-12 production in LPS-stimulated macrophages [10,11]. On the
pro-inflammatory side, in rats treated with RA, the severity of TB
infection is reduced, and this is accompanied by an increase in
NK-cell, T-cell, and macrophage numbers in organs such as the
lung and spleen, along with increased levels of TNF-α, IFN-γ, and
IL-1β [12]. These data clearly show that, when assessing the role
of retinoid signaling, context really matters.
One of the most striking examples of tissue and cell type spe-
cific production and activity of RA has been discovered by study-
ing intestinal dendritic cells (DCs). Iwata et al. have shown that
DCs isolated from mesenteric lymph nodes and Peyer’s patches of
the murine intestine are able to produce RA, also showing that
these cells have the necessary enzymes (alcohol dehydrogenase
III and Raldh2) to convert retinol to RA [13]. The CD103+ DC
subset is capable of inducing robust Treg-cell development [14].
Synthetic antagonists of RAR efficiently blocked Treg-cell develop-
ment [14]. Since then, additional DC subtypes located in the skin
and lung have been shown to produce RA, suggesting that this
activity might not be restricted to gut DCs [15]. A key develop-
ment based on these findings was the dissection of the mechanism
of gut-specific lymphocyte imprinting and oral tolerance and the
involvement of RA. Of note with regard to gut-specific lympho-
cyte imprinting, Iwata et al. showed that T cells primed with RA
showed preferential homing to the gut, that the expression of the
α4β7 integrin and CCR9 on the T cells was essential for this hom-
ing, and that RA induced α4β7 integrin and CCR9 expression in
T lymphocytes [13]. Importantly, in the CD103+ DCs, blocking
RAR led to the inhibition of the induction of gut homing recep-
tors (CCR9 and α4β7) [13]. In addition, DC-derived RA has also
been shown to be important for B-cell gut tropism and IgA pro-
duction [16,17]. Furthermore, in human monocyte derived DCs
induction of endogenous RA production leads to increased CD1d
and reduced CD1a expression and a complete rearrangement of
lipid antigen-presenting capacity, favoring iNKT activation [18].
Regarding the role for RA in oral tolerance, it has been shown
that inducible Treg (iTreg) cells have an important role in main-
taining tolerance and that gut CD103+ DC-derived RA elicits iTreg-
cell development in synergy with TGF-β [14,19,20]. As far as the
molecularmechanism is concerned, RAR has been shown to induce
active histone marks on the promoter of FoxP3, a master regula-
tor of Treg-cell development, and hence to drive FoxP3 expression
[21,22]. RA also blocks the IL-6- and TGF-β-driven induction of
the pro-inflammatory IL-17-producing T (Th17) cells [23].
But here again RA has Janus’s two faces, because it has been
shown that RA is also required for provoking a pro-inflammatory
T-cell response to mucosal vaccination and infection [24]; inhi-
bition of RARα in T cells resulted in a cell autonomous CD4+
T-cell activation defect [24]. Collectively, these data suggest that
endogenously produced RA is critical in shaping T-cell responses,
but its effects are complex and difficult to untangle using only
pharmacological and cellular immunological methods. In vivo
studies complemented with tissue-specific genetic ablation of
either the receptor or key metabolic enzymes are required to gain
further insight.
A new wrinkle is added to these complex roles in this issue
of the European Journal of Immunology by Lee et al. [25], who
use RA pretreatment to assess the contribution of retinoid sig-
naling to immune-driven liver damage using two in vivo models
of hepatitis. One model uses concanavalin A (Con A) to induce
rapid T-cell, granulocyte, and Kupffer cell infiltration in the liver,
leading to hepatocyte death and eventually the death of the ani-
mal [26]. This model is believed to depend on NKT-cell activ-
ity; NKT cells in this model produce large amounts of cytokines,
such as IFN-γ, IL-4, and TNF-α, leading to hepatocyte damage
[27,28]. While animals injected with Con A all died after 6 h,
mice pretreated with RA all survived for at least 24 h [24]. This
remarkable difference is accompanied by reduced levels of IFN-γ
and IL-4, but no change in TNF-α levels [24]. Using a pharma-
cological inhibitor of RA synthesis (Disulfiram), the authors also
showed that the reduction of endogenous RA production could
aggravate Con A-induced hepatitis. By excluding the participa-
tion of other cell types, such as Kupffer cells and Treg cells,
and also by excluding changes in the activation of NKT cells per
se, they pinpointed the changes in cytokine production as the
cause of the in vivo phenotype. Remarkably, in the other model
of NKT cell driven hepatitis, RA pretreatment was ineffective. In
this model, αGalCer, the ligand of CD1d, was administered to
induce hepatic tissue damage [29]. However, this model depends
on FasL and TNF-α rather than IFN-γ, and while the RA-induced
changes in cytokines were similar to those induced in the Con
A model (i.e. reduced levels of IFN-γ and IL-4, but no change
in TNF-α levels), this did not translate into a marked phenotype
in α-GalCer-induced liver injury as these cytokines are not the
phenotype drivers. As far as the mechanisms behind these find-
ing are concerned, the authors propose that RA downregulates
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Figure 1. RA selectively regulates cytokine production in NKT cells.
The left side of the figure shows the metabolic steps leading to all trans-RA production and degradation. The enzymatic step inhibited by
the synthetic enzyme inhibitor, Disulfiram, a compound inhibiting acetaldehyde dehydrogenase and retinaldehyde dehydrogenase as well is
indicated. All trans-RA directly binds to and activates the RAR:RXR heterodimeric receptor, which activates (arrow) or represses (blunt arrow) the
indicated genes expression in the various indicated cell types. The list is partial and is intended only to illustrate the variety of effects RA has on
various immune cells. The new activity identified by Lee et al. in this issue of the European Journal of Immunology [25] is marked by a box.
IFN-γ and IL-4 production by a MAPK-dependent mechanism,
while the NFAT-dependent TNF-α induction would be unaltered,
hence explaining the differential effect on cytokine production
(Fig. 1).
These new data are important as they strongly implicate RA
and, critically, its endogenous production, in the control of NKT-
cell cytokine production and, by doing so, provide new pharmaco-
logical targets for controlling hepatic inflammation in vivo. These
findings also provide support for the concept that lipid signaling,
metabolism, and diet are important in the immune regulation of
T-cell subpopulations. Finally, they also highlight the need for fur-
ther research into themechanistic details of the pathophysiological
and gene regulatory events triggered by RA that, hopefully, will
lead to further therapeutic targets for the regulation of inflamma-
tion.
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